Form 10-QSB for Prolong International Corporation (09/30/2004)
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-QSB

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File No 001-14123

 


 

PROLONG INTERNATIONAL CORPORATION

(Exact name of small business issuer as specified in its charter)

 


 

Nevada   6 Thomas, Irvine, CA 92618   74-2234246

(State or other jurisdiction of

incorporation or organization)

  (Address of principal executive offices)  

(I.R.S Employer

Identification Number)

 

(949) 587-2700

(Issuer’s telephone number)

 

NOT APPLICABLE

(Former name, former address and former fiscal year, if changed since last report)

 


 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

State the number of shares outstanding of each of the issuer’s classes of common equity as of the latest practicable date.

 

Class


 

Outstanding at November 12, 2004


Common Stock, $.001 par value   29,935,848

 

Transitional small business disclosure format:    Yes  ¨    No  x

 

Page 1 of 20 Pages

Exhibit Index on Page 19

 



Table of Contents

PROLONG INTERNATIONAL CORPORATION

FORM 10-QSB

TABLE OF CONTENTS

 

          Page

PART 1

   FINANCIAL INFORMATION     

Item 1:

   Financial Statements     
     Consolidated Condensed Balance Sheets – September 30, 2004 and December 31, 2003    3
     Consolidated Condensed Statements of Operations – Three months and Nine months ended September 30, 2004 and 2003    4
     Consolidated Condensed Statements of Cash Flows – Nine months ended September 30, 2004 and 2003    5
     Notes to Consolidated Condensed Financial Statements    6

Item 2:

   Management’s Discussion and Analysis or Plan of Operation    13

Item 3:

   Controls and Procedures    18

PART II

   OTHER INFORMATION     

Item 1:

   Legal Proceedings    19

Item 2:

   Unregistered Sales of Equity Securities and Use of Proceeds    19

Item 6:

   Exhibits    19

 

2


Table of Contents

PROLONG INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED BALANCE SHEETS

 

    

September 30,

2004

(Unaudited)


   

December 31,

2003


 
ASSETS                 

CURRENT ASSETS:

                

Cash and cash equivalents

   $ 81,478     $ 1,700,666  

Accounts receivable, net of allowance for doubtful accounts of $341,221 at September 30, 2004 and December 31, 2003, respectively

     1,280,683       1,019,052  

Note receivable, current portion

     33,000       24,000  

Inventories, net

     690,013       604,498  

Prepaid television time

     70,330       —    

Prepaid expenses, net

     693,299       622,706  

Advances to employees, current portion

     40,000       50,058  

Net deferred tax assets

     158,384       158,384  
    


 


Total current assets

     3,047,187       4,179,364  

Property and equipment, net (Note 5)

     165,267       234,768  

Note receivable, non-current

     287,437       312,937  

Patents, net

     298,780       353,658  

Trademarks and intangible assets (Note 10)

     2,800,000       3,000,000  

Goodwill

     2,523,302       2,523,302  

Net deferred tax assets, non-current

     157,279       586,279  

Investment in affiliate (Note 9)

     247,524       271,044  

Other assets

     125,749       125,966  
    


 


TOTAL ASSETS

   $ 9,652,525     $ 11,587,318  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

CURRENT LIABILITIES:

                

Accounts payable

   $ 1,203,446     $ 826,475  

Accrued expenses

     1,044,897       1,038,631  

Line of credit (Note 6)

     814,290       737,564  

Notes payable, current (Note 7)

     284,345       653,852  

Deferred gain, current (Note 3)

     218,534       218,534  
    


 


Total current liabilities

     3,565,512       3,475,056  

Deferred gain, non-current (Note 3)

     273,167       437,066  

Notes payable, non-current (Note 7)

     1,911,828       1,756,998  
    


 


Total liabilities

     5,750,507       5,669,120  

COMMITMENTS AND CONTINGENCIES (Note 1, 6, 7 and 8)

                

STOCKHOLDERS’ EQUITY:

                

Preferred stock, $0.001 par value; 50,000,000 shares authorized;
no shares issued or outstanding

     —         —    

Common stock, $0.001 par value; 150,000,000 shares authorized;
29,900,848 and 29,789,598 shares issued and outstanding at September 30, 2004 and December 31, 2003

     29,901       29,789  

Additional paid-in capital

     16,515,564       16,408,851  

Accumulated deficit

     (12,643,447 )     (10,520,442 )
    


 


Total stockholders’ equity

     3,902,018       5,918,198  
    


 


TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 9,652,525     $ 11,587,318  
    


 


 

See Notes to Consolidated Condensed Financial Statements

 

3


Table of Contents

PROLONG INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

 

    

Three Months Ended

September 30,


   

Nine Months Ended

September 30,


 
     2004

    2003

    2004

    2003

 
           (As Restated)
See Note 3
         

(As Restated)

See Note 3

 

NET REVENUES

   $ 1,951,585     $ 2,223,794     $ 6,555,228     $ 6,445,707  

COST OF GOODS SOLD

     728,689       769,836       2,313,282       2,247,007  
    


 


 


 


GROSS PROFIT

     1,222,896       1,453,958       4,241,946       4,198,700  

OPERATING EXPENSES:

                                

Selling and marketing

     1,168,086       824,717       3,290,090       2,639,377  

General and administrative

     683,340       632,431       2,272,996       2,003,016  

Impairment charge

     —         —         200,000       —    
    


 


 


 


Total operating expenses

     1,851,426       1,457,148       5,763,086       4,642,393  
    


 


 


 


OPERATING (LOSS)

     (628,530 )     (3,190 )     (1,521,140 )     (443,693 )

OTHER INCOME (EXPENSE), net:

                                

Interest expense

     (153,826 )     (93,973 )     (466,786 )     (298,078 )

Interest income

     5,391       5,786       17,611       5,823  

Related party other income

     23,985       24,303       71,955       58,311  

Other income

     9,339       100,665       40,456       135,039  

Gain on sale of building (Note 3)

     54,633       54,633       163,899       163,899  
    


 


 


 


Total other income (expense)

     (60,478 )     91,414       (172,865 )     64,994  
    


 


 


 


(LOSS) INCOME BEFORE PROVISION FOR INCOME TAXES

     (689,008 )     88,224       (1,694,005 )     (378,699 )

PROVISION FOR INCOME TAXES

     316,000       490,000       429,000       790,000  
    


 


 


 


NET (LOSS)

   $ (1,005,008 )   $ (401,776 )   $ (2,123,005 )   $ (1,168,699 )
    


 


 


 


NET (LOSS) PER SHARE

                                

Basic and Diluted:

                                

Net (loss)

   $ (0.03 )   $ (0.01 )   $ (0.07 )   $ (0.04 )
    


 


 


 


WEIGHTED AVERAGE COMMON SHARES

                                

Basic and Diluted:

     29,900,848       29,789,598       29,875,597       29,789,598  
    


 


 


 


 

See Notes to Consolidated Condensed Financial Statements

 

4


Table of Contents

PROLONG INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

 

     Nine Months Ended
September 30,


 
     2004

    2003

 
           (As Restated)
See Note 3
 

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net (loss)

   $ (2,123,005 )   $ (1,168,699 )

Adjustments to reconcile net (loss) to net cash used in operating activities:

                

Gain from sale of building

     (163,899 )     (163,899 )

Sublease income from affiliate

     —         (58,331 )

Depreciation and amortization

     136,674       137,882  

Provision for (recovery of) doubtful accounts

     75,000       (78,321 )

Deferred taxes

     429,000       790,000  

Reserve for inventory obsolescence

     (6,934 )     (23,250 )

Gain from conversion of notes payable sub-debt

     —         (92,833 )

Intangible asset impairment

     200,000       —    

Amortization of debt discount related to warrants issued to sub-debt creditors

     178,889       97,755  

Compensation costs related to transfer of stock in affiliate

     112,500       —    

Gain from transfer of stock in affiliate

     (8,280 )     —    

Write-off in connection with accounts receivable conversion to note receivable

     —         80,000  

Changes in assets and liabilities:

                

Accounts receivable

     (336,631 )     (209,775 )

Note receivable

     16,500       4,000  

Inventories

     (78,581 )     20,115  

Prepaid expenses

     (70,593 )     21,622  

Prepaid television time

     (70,330 )     —    

Other assets

     (17,425 )     16,556  

Accounts payable

     376,971       176,673  

Accrued expenses

     6,266       165,812  
    


 


Net cash used in operating activities

     (1,343,878 )     (284,693 )

CASH FLOWS FROM INVESTING ACTIVITIES:

                

Purchases of property and equipment

     (12,295 )     (11,043 )

Employee advances

     27,700       22,837  

Investment in affiliate

     15,000       —    
    


 


Net cash provided by investing activities

     30,405       11,794  

CASH FLOWS FROM FINANCING ACTIVITIES:

                

Proceeds from notes payable sub-debt

     250,000       260,000  

Payments on notes payable sub-debt

     (643,566 )     (189,428 )

Net proceeds (payments) from line of credit from bank

     76,726       (6,199 )

Proceeds from issuance of common stock

     11,125       —    
    


 


Net cash (used in) provided by financing activities

     (305,715 )     64,373  

NET (DECREASE) IN CASH AND CASH EQUIVALENTS

     (1,619,188 )     (208,526 )

CASH AND CASH EQUIVALENTS, beginning of period

     1,700,666       261,623  
    


 


CASH AND CASH EQUIVALENTS, end of period

   $ 81,478     $ 53,097  
    


 


SUPPLEMENTAL CASH FLOW DISCLOSURES:

                

Income taxes paid

   $ 1,600     $ 1,600  
    


 


Interest paid

   $ 287,897     $ 200,323  
    


 


 

SUPPLEMENTAL NONCASH INVESTING AND FINANCING ACTIVITIES

 

During 2004, the Company completed the following transactions:

 

Recorded a decrease of $163,899 to deferred gain related to the gain on sale of building.

 

Recorded compensation costs of $112,500, offset with a recorded increase to additional paid in capital of $95,700 related to the transfer of stock in affiliate.

 

During 2003, the Company completed the following transactions:

 

Provided an affiliate with office space, and recorded increases in other income and investment in affiliate of $58,331.

 

Recorded a decrease of $163,899 to deferred gain related to the gain on sale of building.

 

Converted $427,437 of accounts receivable to a $347,437 note receivable and recorded a related charge of $80,000.

 

The holders of $260,000 of notes payable sub-debt converted their notes, $8,000 of accrued interest thereon, and warrants to purchase 167,063 shares of the Company’s common stock at $0.20 per share into 767,000 shares of Oryxe Energy International common stock with a net book value of $112,000 and warrants to purchase 400,000 shares of the Company’s common stock at $0.09 per share with an estimated fair value of $63,000. In connection with this transaction, the Company recognized a gain upon conversion of the notes of approximately $93,000.

 

See Notes to Consolidated Condensed Financial Statements

 

5


Table of Contents

PROLONG INTERNATIONAL CORPORATION

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

 

1. BUSINESS

 

Prolong International Corporation (PIC) is a Nevada corporation originally organized on August 24, 1981. In September 1995, PIC acquired 100% of the outstanding stock of Prolong Super Lubricants, Inc. (PSL), a Nevada corporation. In 1998, Prolong International Holdings Ltd. was formed as a wholly owned subsidiary of PIC. At the same time, Prolong International Ltd. was formed as a wholly owned subsidiary of Prolong International Holdings Ltd. PIC, through its subsidiaries, is engaged in the manufacture, sale and worldwide distribution of a patented complete line of high-performance and high-quality lubricants and appearance products.

 

Management’s Plans Regarding Financial Results and Liquidity – At September 30, 2004, the Company had negative working capital of approximately $519,000 and an accumulated deficit of approximately $12,643,000. The Company initiated vigorous expense-reduction strategies during the years 2003 and 2004 to date. During 2003 and 2004 to date, the Company reduced personnel, discontinued certain of its endorsement and sponsorship contracts which have been offset with increases in infomercial production costs and sales allowances to promote the sales effort. Additionally, the Company improved its credit and collections function and worked with its vendors to improve payment terms. The Company also recorded a one-time deferred gain aggregating $983,400 that will be recognized ratably through December 31, 2006 pursuant to the terms of the existing facility lease agreement, on the sale of its corporate headquarters during the year ended December 31, 2002. During 2003, the Company raised additional working capital of $260,000 through a private placement offering of convertible promissory notes and common stock purchase warrants to accredited investors (see Note 9) and $2,500,000 through the sale and issue of subordinated secured promissory notes and common stock purchase warrants to institutional investors (See Note 7). During 2004 to date, the Company raised additional working capital of $250,000 through the sale and issue of subordinated secured promissory notes to institutional investors. (See Note 7) If these measures are not adequate, the Company will pursue additional expense reductions or seek to raise additional funds through debt or equity financings. If additional funds are raised by issuing equity securities, dilution to existing stockholders is likely to result. Management believes that a portion of the shares of common stock in Oryxe Energy International, Inc. owned by the Company could be sold to provide additional working capital (see Note 7 and Note 9). Management believes that the aforementioned plans, if successfully executed, will provide adequate financial resources to sustain the Company’s operations and enable the Company to continue as a going concern.

 

2. BASIS OF PRESENTATION

 

The accompanying unaudited consolidated condensed financial statements include the accounts of PIC and its wholly-owned subsidiaries, PSL, Prolong International Holdings Ltd. and its wholly-owned subsidiary, Prolong International Ltd. (collectively, the Company or Prolong). All intercompany accounts have been eliminated in consolidation. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the instructions to Form 10-QSB and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2004 are not necessarily indicative of the results that may be expected for the year ending December 31, 2004. For further information, refer to the Form 10-K/A for the year ended December 31, 2003 filed by the Company with the Securities and Exchange Commission.

 

3. RESTATEMENT OF PRIOR YEAR INTERIM PERIOD

 

In connection with the sale of the Company’s land and building, the Company originally recognized a related gain of $983,000 during the year ended December 31, 2002, which was the period in which the Company’s legal and contractual obligations under the related mortgage debts were completely satisfied. Subsequently, management determined that the Company’s future involvement with the property did not

 

6


Table of Contents

satisfy the “minor” definition as provided in SFAS No. 28, “Accounting for Sales with Leasebacks,” because of the terms of the Company’s lease agreement with the purchaser of the property. As a result, the gain on the sale of the Company’s land and building should be amortized on a straight-line basis over the term of the Company’s lease agreement, beginning on June 28, 2002, which is the date that the Company became legally released from its related mortgage debt obligations. The impact of this restatement was to decrease the amount of the gain on sale that was recognized in 2002 from $983,000 to $109,000 and record a deferred gain of $874,000 as of December 31, 2002 that will be recognized ratably through December 31, 2006. The Company recognized a gain on sale of building of $163,899 in the nine months ended September 30, 2004 and September 30, 2003, respectively.

 

4. INVENTORIES

 

Inventories consist of the following:

 

    

September 30,

2004


    December 31,
2003


 
     (Unaudited)        

Raw materials

   $ 361,441     $ 246,500  

Finished goods

     361,916       398,276  

Obsolescence reserve

     (33,344 )     (40,278 )
    


 


     $ 690,013     $ 604,498  
    


 


 

5. PROPERTY AND EQUIPMENT

 

Property and equipment consists of the following:

 

    

September 30,

2004


    December 31,
2003


 
     (Unaudited)        

Computer equipment

   $ 309,074     $ 298,127  

Office equipment

     57,101       55,753  

Furniture and fixtures

     585,168       585,168  

Automotive equipment

     35,925       35,925  

Exhibit equipment

     130,482       130,482  

Machinery and equipment

     19,817       19,817  

Molds and dies

     233,117       233,117  
    


 


       1,370,684       1,358,389  

Less accumulated depreciation

     (1,205,417 )     (1,123,621 )
    


 


     $ 165,267     $ 234,768  
    


 


 

6. LINE OF CREDIT

 

Effective February 26, 2003, the Company entered into a $1,500,000 credit facility with a financial institution that, unless terminated earlier by its terms, has an initial term through February 26, 2005 with automatic renewals for successive one-year periods thereafter. The credit facility provides for advances of funds up to 75% of the gross face value of eligible trade accounts receivable based on agreed terms. Such facility is collateralized by accounts receivable, inventory, equipment and other assets. Interest is payable monthly at the financial institution’s base index, which was 4.75% at September 30, 2004, plus 2.25%. Additionally, the Company is obligated to pay the lender (i) a monthly purchasing fee equal to 0.25% of the total monthly average advances outstanding and (ii) an annual facility fee equal to 0.75% of the purchasing limit (which limit is currently $1,500,000). As of September 30, 2004, $814,290 was outstanding under the credit facility.

 

7


Table of Contents
7. NOTES PAYABLE

 

Notes payable consist of the following as of September 30, 2004

 

a)      Various subordinated secured promissory notes payable to accredited investors bearing interest at 15% per annum to be repaid under various terms in monthly principal and interest through June 30, 2005.

   $ 117,562

 

b)      Four subordinated secured promissory notes payable to accredited investors in 2003 to be repaid as follows:

     2,500,000

 

1)      Monthly interest only payments at 8% per annum for the period November 24, 2003 through September 30, 2004.

 

2)      Monthly interest only payments at 14% per annum for the period July 1, 2004 through November 30, 2004.

 

3)      Monthly principal and interest payments of $46,850 at 14% per annum for the period December 1, 2004 through October 31, 2008.

 

4)      All unpaid principal and interest to be paid in a lump sum payment on November 24, 2008. The securities purchase agreement contains certain defined EBITDA ratio’s and tangible net worth financial covenants. (see below)

 

5)      On August 11, 2004, the Company amended the securities purchase agreement entered into on November 24, 2003 to:

 

•      Postpone the financial covenants related to Tangible Net Worth and EBITDA until after December 31, 2005 with new ratios to be mutually decided upon on or before June 30, 2005.

 

•      Adjust the commencement of the scheduled increase in interest payments as follows:

 

•      Interest rate from July 31, 2004 – December 31, 2004 will be 11% cash pay; thereafter interest rate will be 14%.

 

•      An additional 3% interest will accrue from July 31, 2004 – December 31, 2004 and be payable at maturity.

 

•      Postpone commencement of cash payments of royalties from the quarter ended September 30, 2004 to March 31, 2005. Royalties will continue to accrue during the period as outlined in the royalty participation agreement. The royalties that accrue from September 30, 2004 - March 31, 2005, June 30, 2005, September 30, 2005 and December 31, 2005.

 

Lastly, the parties amended the warrants issued pursuant to the securities purchase agreement to provide that the warrants shall only become exercisable for an additional ten percent of the Company’s outstanding shares of common stock upon a payment default by the Company.

 

The Company also agreed to remit, on a pro rata basis to the holders of secured promissory notes issued thereunder, fifty percent of the proceeds in excess of the Company’s cost basis which are received by the Company from sales of its holdings of common stock and warrants of Oryxe Energy International, Inc. (“Oryxe”), immediately upon such sale. Additionally, the Company agreed to remit to the holders of the secured promissory notes fifty percent of the proceeds from the sale of license of the Company’s license and development rights with Oryxe for certain Oryxe technology. (See Note 9).

      

 

8


Table of Contents

If the Company manufactures, distributes or sells any product that incorporate technology or other rights covered by an Oryxe License (“Covered Products”), St. Cloud Capital Partners LP and affiliates shall be entitled to 3% of net revenues derived from such Covered Products for a period of four years from the date that distribution of such Covered Products commences (it being understood that such net revenues shall not be included in Incremental Revenue for purposes of Section 6.1 in the original Securities Purchase Agreement).

        

 

c)      Four subordinated secured promissory notes payable to accredited investors in 2004 in connection with the amendment to the securities purchase agreement (See Note 7b and 9) to be repaid as follows:

 

     250,000  

 

1) Principal and accrued interest at 8% per annum are all due on November 24, 2008. (See Note 9)

        
    


       2,867,562  

Less current maturities

     (284,345 )
    


       2,583,217  

Less unamortized debt discount relating to the relative estimated fair value of warrants issued.

     (671,389 )
    


     $ 1,911,828  
    


 

The following are the remaining annual minimum principal payments due under the subordinated secured promissory notes:

 

Year ending December 31,

      

2004

   $ 46,215

2005

     374,520

2006

     266,271

2007

     306,037

2008

     1,874,519
    

     $ 2,867,562
    

 

In connection with the Company’s issuance of the subordinated secured promissory notes payable in 2002 described in (a) above, the Company issued warrants to purchase an aggregate of 2,250,000 shares of common stock to related note holders and warrants to purchase an aggregate of 247,000 shares of common stock as broker commissions. Each warrant allows the holder to purchase one share of the Company’s common stock at $0.09 per share for a period of five years. In accordance with APB No. 14, the Company has presented the relative estimated fair value of the warrants issued to note holders of $209,000 as a debt discount and such amount is being amortized over the expected terms of the promissory notes. As of September 30, 2004 there was no remaining debt discount.

 

In connection with the Company’s issuance of the secured promissory notes payable in 2003 described in (b) above, the Company issued warrants to purchase an aggregate of 5,957,918 shares of common stock to related note holders and warrants to purchase an aggregate of 595,791 shares of common stock as broker commissions. Each warrant issued to the note holders allows the note holder to purchase one share of the Company’s common stock at $0.06 per share for a period of ten years and the broker commission warrants entitle the holder to purchase shares of the Company’s common stock at $0.24 per share for a period of ten years. In accordance with APB No. 14, the Company has presented the relative estimated fair value of the warrants issued to note holders of $805,666 as a debt discount and such amount is being amortized over the expected terms of the promissory notes. As of September 30, 2004 the remaining debt discount was $671,389.

 

9


Table of Contents
8. CONTINGENCIES

 

On April 8, 1997, a lawsuit was filed by Francis Helman et al vs. EPL Prolong Inc. and PIC et al in the Court of Common Pleas, Columbiana County, Ohio. The operative complaint alleges breach of contract, fraudulent conveyance of corporate assets, breach of fiduciary duties, breach of an alleged novation and fraud in the inducement relating to the alleged novation. Plaintiffs allege that they purchased certain “pre-primary shares” of stock in a Canadian company known as Prolong Industries Inc. from Defendant Ronald Sloan and other agents of the Canadian company during the period of May 1985 through October 1987, a period prior in time to the formation of EPL Prolong, Inc. It remains undisputed that the EPL Defendants had no involvement in the solicitation or sale of the pre-primary shares that were allegedly sold to the plaintiffs between 1985 and 1987. A settlement of the dispute as a class action has been reached and the Court has filed a Final Judgment and Order of Dismissal. It is expected that the Company will issue approximately 1,111,538 shares of common stock of the Company to the plaintiffs and their legal counsel coincident to the settlement agreement and pay $24,000 of their litigation expenses. It is anticipated that the issuance of stock will take place during the fourth quarter of fiscal year 2004. The settlement expense has been fully reserved for in prior periods. It is not expected that the settlement will have an adverse material effect on the financial position, results of operations or cash flows of the Company.

 

Prolong International Corporation and its subsidiaries are subject to other legal proceedings, claims, and litigation arising in the ordinary course of business. The Company’s management does not expect that the ultimate costs to resolve these matters will have a material adverse affect on it’s consolidated financial position, results of operations or cash.

 

9. INVESTMENT IN AFFILIATE

 

On March 31, 2001, the Company entered into an Organization Agreement with Prolong Environmental Energy Corporation (PEEC), a California Corporation, whereby the Company agreed to contribute up to $150,000 to PEEC as required to meet the operating working capital obligations for PEEC. In exchange PIC was issued 1,008,564 shares of common stock in PEEC, as well as a fully-vested warrant to purchase an additional 2,625,415 shares of common stock at a price of $.171 per share. In December 2001, PEEC was merged into Oryxe Energy International, Inc., a Delaware corporation (“Oryxe”). The Company provided Oryxe with administrative and facilities services support in the amount of $233,324 during the period April 1, 2001 through July 31, 2003. In exchange for the Company’s investment, and the services provided (total investment of $383,324), the Company acquired approximately 10% of the issued and outstanding common stock of Oryxe.

 

During the quarter ended June 30, 2003, the Company issued convertible promissory notes which were cancelled in exchange for the transfer of 766,875 shares of Oryxe Common Stock. In connection with this transaction, the Company issued warrants to purchase an aggregate of 400,000 shares of the Company’s common stock at $0.09 per share having an estimated fair value aggregating $63,291. During the quarter ended June 30, 2004, the Company transferred 60,000 shares of Oryxe Common Stock in exchange for $15,000 to two investors and transferred 150,000 shares of Oryxe Common Stock to certain employees and directors as compensation for services provided. These transactions reduced the Company’s investment in Oryxe to $247,524, which represents an approximate 6% interest in Oryxe as of September 30, 2004.

 

On August 11, 2004, the Company amended the securities purchase agreement entered into November 24, 2003 with certain institutional investors (See Note 7b and 7c), whereby the Company agreed to remit, on a pro rata basis to the holders of secured promissory notes issued thereunder, fifty percent of the proceeds in excess of the Company’s cost basis which are received by the Company from sales of its holdings of common stock and warrants of Oryxe, immediately upon such sale. Additionally, the Company agreed to remit to the holders of the secured promissory notes fifty percent of the proceeds from the sale of license of the Company’s license and development rights with Oryxe for certain Oryxe technology.

 

If the Company manufactures, distributes or sells any product that incorporate technology or other rights covered by an Oryxe License (“Covered Products”), St. Cloud Capital Partners LP and affiliates shall be entitled to 3% of net revenues derived from such Covered Products for a period of four years from the date that distribution of such Covered Products commences (it being understood that such net revenues shall not be included in Incremental Revenue for purposes of Section 6.1 in the original Securities Purchase Agreement).

 

10


Table of Contents
10. INTANGIBLE ASSETS

 

Effective the beginning of the first quarter of 2002, the Company completed the adoption of SFAS No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets. SFAS No. 141 requires all business combinations initiated after June 30, 2001 to be accounted for using the purchase method of accounting. As required by SFAS No. 142, the Company discontinued amortizing the remaining balance of goodwill as of the beginning of fiscal 2002. All remaining and future acquired goodwill, and intangible assets with indefinite useful lives, will be subject to impairment tests annually, or earlier if indicators of potential impairment exist, using a fair-value-based approach. All other intangible assets will continue to be amortized over their estimated useful lives and assessed for impairment under SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets.

 

In connection with the preparation of the Company’s September 30, 2004 consolidated condensed financial statements and related Form 10-QSB, management determined it necessary to perform an interim impairment test with respect to its trademarks and goodwill, as events and changes in circumstances may have occurred that may indicate that such assets might be impaired. Management believes that this interim test is appropriate in light of the Company’s current year-to-date and period operating losses, cash flow utilization, and under-performance relative to year-to-date forecasted financial results.

 

Accordingly, management performed (1) a fair value assessment of the Company’s trademarks and patents, and (2) a fair value assessment of the Company as of September 30, 2004. Such fair value estimates were determined by using an average of the multi-period discounted cash flow, or income method, and the market method of valuation. Based on these assessments, the Company did not record an impairment charge during the quarter ended September 30, 2004 (although, the Company determined that the fair value of its trademarks as of June 30, 2004 was $2,800,000 and therefore recorded an impairment charge in the amount of $200,000 with respect to its trademarks for such period). Such amount has been presented as a single line item in the Company’s consolidated condensed statements of operations during the quarter ended June 30, 2004 and the nine months ended September 30, 2004.

 

11. STOCK OPTIONS

 

SFAS No. 123 and No. 148 require the determination and disclosure of compensation costs implicit in stock option grants or other stock rights. The Company has adopted certain required provisions of this standard for non-employee transactions. Under the employee transaction provisions, companies are encouraged, but not required, to adopt the fair value of accounting for employee stock-based transactions. Companies are also permitted to continue to account for such transactions under Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees. The following table illustrates the effect on net income if the Company had applied the fair value recognition provisions of SFAS No. 123 to stock-based employee compensation.

 

    

Nine Months Ended

September 30, 2004


 
     (unaudited)  

Net (loss) as reported

   $ (2,123,005 )

Total stock-based employee compensation determined under fair value based method, net of related tax effects

     (53,100 )
    


Net (loss), pro forma

   $ (2,176,105 )
    


Earnings (loss) per share:

        

Basic – as reported

   $ (0.07 )

Basic – pro forma

   $ (0.07 )

Diluted – as reported

   $ (0.07 )

Diluted – pro forma

   $ (0.07 )

 

11


Table of Contents

Effective June 4, 1997, the Company adopted the Prolong International Corporation 1997 Stock Incentive Plan (the “Plan”). Under the Plan, the Company may grant nonqualified or incentive stock options for the benefit of qualified employees, officers, directors, consultants and other service providers. On June 26, 2002, the Company’s stockholders approved an increase of 1,500,000 shares of common stock issuable under the Plan, bringing the total number of authorized shares to 4,000,000. The term of the option is fixed by the administrator of the Plan, but no option may be exercisable more than 10 years after the date of grant.

 

Stock option activity is as follows:

 

     Shares under
option


   

Weighted
average exercise
price

per share


 

OUTSTANDING, December 31, 2002

   2,066,500     $ 0.19  

Granted

   —         —    

Canceled

   (206,000 )   $ 0.19  

Exercised

   —         —    
    

       

OUTSTANDING, December 31, 2003

   1,860,500     $ 0.19  

Granted

   —         —    

Canceled

   (25,500 )   $ (0.10 )

Exercised

   (111,250 )   $ (0.10 )
    

       

OUTSTANDING, September 30, 2004

   1,723,750     $ 0.10  
    

       

 

Outstanding options vest over periods ranging from one to five years. During the nine months ended September 30, 2004, there were no options issued by the Company to either outside consultants or employees.

 

As of September 30, 2004, options to purchase 1,099,375 shares of common stock were exercisable.

 

The fair value of options granted is estimated on the date of grant using the Black-Scholes option-pricing model that considers various weighted average assumptions, including dividend yields, expected volatility of Company stock, risk-free interest rates, and expected option life.

 

12


Table of Contents

ITEM 2:

 

PROLONG INTERNATIONAL CORPORATION

MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

 

RISK FACTORS AND FORWARD LOOKING STATEMENTS

 

This report contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. In addition, the Company may from time to time make oral forward looking statements. The words “estimate,” “project,” “potential,” “intended,” “expect,” “anticipate,” “believe” and similar expressions or words are intended to identify forward looking statements. The forward looking statements included herein are based on current expectations, which involve a number of risks and uncertainties and assumptions regarding the Company’s business and technology. These assumptions involve judgments with respect to, among other things, future economic and competitive conditions, and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes that the assumptions underlying the forward looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the results contemplated in forward looking statements will be realized and actual results may differ materially. In light of the significant uncertainties inherent in the forward looking information included herein, the inclusion of such information should not be regarded as a representation by the Company or any other person that the objectives or plans of the Company will be achieved. The Company undertakes no obligation to publicly release the result of any revisions to these forward looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.

 

Actual results are uncertain and may be impacted by the factors discussed in more detail in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2003 and other periodic reports filed with the Securities and Exchange Commission. In particular, there are certain risks and uncertainties that may impact the accuracy of the forward looking statements with respect to revenues, expenses and operating results including without limitation, the risks set forth in the risk factors section of the Annual Report on Form 10-K/A for the year ended December 31, 2003, which risk factors are hereby incorporated into this report by this reference. As a result, the actual results may differ materially from those projected in the forward looking statements.

 

Because of these and other factors that may affect the Company’s operating results, past financial performance should not be considered an indicator of future performance, and investors should not use historical trends to anticipate results or trends in future periods.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during the reporting period. The Company regularly evaluates its estimates and assumptions related to allowances for doubtful accounts, sales returns and allowances, inventory reserves, goodwill and purchased intangible asset valuations, deferred income tax asset valuation allowances, warranty reserves, litigation and other contingencies. The Company bases its estimates and assumptions on historical experience, forecasted operating results and expected trends, and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. To the extent there are material differences between the Company’s estimates and the actual results, its future results of operations will be affected. The Company believes the following critical accounting policies require it to make significant judgments and estimates in the preparation of its consolidated financial statements:

 

Revenue, Receivables and Inventory - The Company recognizes product revenue upon concluding that all of the fundamental criteria for revenue recognition have been met. The criteria are usually met at the time of product shipment. In addition, the Company records reductions to revenue for estimated product returns and allowances for volume discount programs. Should actual product returns or pricing adjustments exceed the Company’s estimates, additional reductions to revenue would result. The Company provides reserves for estimated product warranty costs at the time revenue is recognized. The Company maintains an allowance for doubtful accounts for estimated losses

 

13


Table of Contents

resulting from the inability of customers to make required payments. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances could be required. The Company records reserves against its inventory for estimated obsolescence. If actual market conditions are less favorable than those projected by management, additional inventory write-downs could be required.

 

Goodwill and Purchased Intangible Assets - The purchase method of accounting for acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of the net tangible and intangible assets acquired. Goodwill and intangible assets deemed to have indefinite lives are no longer amortized but are subject to at least annual impairment tests. Management obtains an annual independent, third party valuation of the Company to assist it in the performance of annual impairment tests, or more frequent tests if necessary. The amounts and useful lives assigned to intangible assets impact future amortization.

 

Deferred Taxes - If the Company determines that it is more likely than not that it will not realize all or part of its net deferred tax assets in the future, it will record a valuation allowance against the deferred tax assets, which allowance will be charged to income tax expense in the period of such determination. Management considers the scheduled reversal of deferred tax liabilities, tax planning strategies and future taxable income in assessing the realizability of deferred tax assets. Management also considers the weight of both positive and negative evidence in determining whether a valuation allowance is needed.

 

RESULTS OF OPERATIONS

 

The following table shows the Company’s operating results as a percentage of net revenues.

 

    

Three Months Ended

September 30,


   

Nine Months Ended

September 30,


 
     2004

    2003

    2004

    2003

 
          

(As Restated)

in Note 3

         

(As Restated)

in Note 3

 

Net revenues

   100.0     100.0     100.0     100.0  

Cost of goods sold

   37.3     34.6     35.3     34.9  
    

 

 

 

Gross profit

   62.7     65.4     64.7     65.1  

Selling and marketing expenses

   59.8     37.1     50.2     40.9  

General and administrative expenses

   35.0     28.4     34.7     31.1  

Impairment charge

   —       —       3.1     —    
    

 

 

 

Operating (loss) income

   (32.1 )   (0.1 )   (23.3 )   (6.9 )

Other (expense) income

   (3.1 )   4.1     (2.6 )   1.0  
    

 

 

 

(Loss) before income taxes

   (35.2 )   4.0     (25.9 )   (5.9 )

Provision for income taxes

   (16.2 )   (22.0 )   (6.5 )   (12.3 )
    

 

 

 

Net (loss)

   (51.4 )   (18.0 )   (32.4 )   (18.2 )
    

 

 

 

 

Three Months Ended September 30, 2004 vs. Three Months Ended September 30, 2003

 

Net revenues for the three months ended September 30, 2004 were approximately $1,952,000 as compared to approximately $2,224,000 for the comparable period of the prior year, a decrease of $272,000 or 12.2%. Revenues for the three month period ended September 30, 2004 consisted of retail sales of $1,518,000 and international and other sales of $434,000. Revenues for the three month period ended September 30, 2003 consisted of retail sales of $1,879,000, and international and other sales of $345,000.

 

During the three months ended September 30, 2004, retail sales were 77.8% of total revenues while international and other sales comprised 22.2% of total revenues. During the three months ended September 30, 2003, retail sales were 84.5% of total revenues while international and other sales comprised 15.5% of total revenues. During the three months ended September 30, 2004, international and other sales increased $89,000 from the comparable period in 2003 primarily as a result of new incremental sales in China and increased sales in the industrial division related to the new distributor program. The lubricant retail sales decline of $361,000 is attributable to a soft market for aftermarket automotive lubricants, competitive factors and general economic factors.

 

14


Table of Contents

Cost of goods sold for the three months ended September 30, 2004 was approximately $729,000 as compared to $770,000 for the comparable period of the prior year, a decrease of $41,000 or 5.3%. As a percentage of net revenues, cost of goods sold increased from 34.6% for the three months ended September 30, 2003 to 37.3% for the three months ended September 30, 2004. The increase in 2004 was mainly attributable to a shift in sales mix in international sales with lower gross margins, and the recording of inventory cycle counts adjustments in the period.

 

Selling and marketing expenses of $1,168,000 for the three months ended September 30, 2004 represented an increase of $343,000 over the comparable period of the prior year. This 41.6% increase was primarily the result of increased expenses in customer sales allowances to promote the sales efforts, increased spending in television media advertising and production costs related to a new infomercial aired in July 2004. Selling and marketing expenses as a percentage of net revenues were 59.8% for the period ended September 30, 2004 versus 37.1% for the previous year.

 

General and administrative expenses for the three months ended September 30, 2004 were approximately $683,000 as compared to $632,000 for the three months ended September 30, 2003, an increase of $51,000 or 8.1%. This increase is mainly attributable to an increase in bad debt expense of $75,000. As a percentage of net revenues, general and administrative expenses increased from 28.4% in 2003 to 35.0% in 2004.

 

Net interest expense of $154,000 for the three months ended September 30, 2004 represented an increase of $60,000 from the comparable period in 2003. The increase is attributable to the additional interest expenses relating to the secured promissory notes issued by the Company in November 2003.

 

Other income (expense) for the three months ended September 30, 2004 was $9,300 as compared to $100,700 for the three months ended September 30, 2003 mainly due to a one-time net gain of $92,800 from the exchange of approximately 766,000 shares of common stock held in the Company’s affiliate, Oryxe Energy International, Inc., for the relief of $260,000 of subordinated notes payable. The gain on the sale of building was $54,600 respectively for the three months ended September 30, 2004 and September 30, 2003 (See Note 3 to consolidated condensed financial statements).

 

The provision for income taxes was $316,000 for the three month period ended September 30, 2004 as compared to $490,000 for the three months ended September 30, 2003. The provisions resulted from an increase in the valuation allowance recorded against a portion of the Company’s deferred tax assets. Such allowance was recorded as management could not determine that it was more likely than not that such deferred tax assets would be realized.

 

Net loss for the three month period ended September 30, 2004 was approximately $1,005,000 as compared to a net loss of approximately $402,000 for the comparable period in the prior year, an increase of $603,000. The increase is a result of the factors discussed above.

 

Nine Months Ended September 30, 2004 vs. Nine Months Ended September 30, 2004

 

Net revenues for the nine months ended September 30, 2004 were approximately $6,555,000 as compared to approximately $6,446,000 for the comparable period of the prior year, an increase of $109,000 or 1.7%. Revenues for the nine month period ended September 30, 2004 consisted of retail sales of $5,089,000 and international and other sales of $1,466,000. Revenues for the nine month period ended September 30, 2003 consisted of retail sales of $5,581,000, and international and other sales of $865,000.

 

During the nine months ended September 30, 2004, retail sales were 77.6% of total revenues while international and other sales comprised 22.4% of total revenues. During the nine month period ended September 30, 2003, retail sales were 86.6% of total revenues while international and other sales comprised 13.4% of total revenues. During the nine months ended September 30, 2004, international and other sales increased $601,000 from the comparable period in 2003, primarily as result of new incremental sales in China, Hungary and Mexico and increased sales in the industrial division related to the new distributor program. The lubricant retail sales decline of $492,000 is attributable to a soft market for aftermarket automotive lubricants, competitive factors and general economic factors.

 

Cost of goods sold for the nine months ended September 30, 2004 was approximately $2,313,000 as compared to $2,247,000 for the comparable period of the prior year, an increase of $66,000 or 2.9%. As a percentage of net

 

15


Table of Contents

revenues, cost of goods sold increased from 34.9% for the nine months ended September 30, 2003 to 35.3% for the nine months ended September 30, 2004. The increase in 2004 was mainly attributable to a shift in sales mix in international sales with lower gross margins, and the recording of inventory adjustments.

 

Selling and marketing expenses of $3,290,000 for the nine months ended September 30, 2004 represented an increase of $651,000 over the comparable period of the prior year. This 24.7% increase was primarily the result of increased expenses in customer sales allowances to promote the sales efforts, increased spending in television media advertising and production costs related to a new infomercial aired in July 2004. Selling and marketing expenses as a percentage of net revenues were 50.2% for the period ended September 30, 2004 versus 40.9% for the previous year.

 

General and administrative expenses for the nine months ended September 30, 2004 were approximately $2,273,000 as compared to $2,003,000 for the nine months ended September 30, 2003, an increase of $270,000 or 13.5%. This increase was mainly attributable to an increase in fees to professional advisors in connection with a registration statement that the Company was required to file with respect to the November 2003 debt financing, a charge of $112,500 for compensation costs related to a transfer of stock in an affiliate and an increase in bad debt expenses. As a percentage of net revenues, general and administrative expenses increased from 31.1% in 2003 to 34.7% in 2004.

 

Impairment charge expense of $200,000 for the nine months ended September 30, 2004 relates to the impairment charge with respect to its trademarks. The Company determined to perform an interim impairment test as of June 30, 2004 with respect to its trademarks and goodwill as events and changes in circumstances may have occurred that may indicate that such assets might be impaired. Based on the Company’s analysis of the valuation reports the Company recorded the impairment charge. See Note 10 to the condensed consolidated financial statements contained elsewhere in this Quarterly Report for a further discussion of this impairment charge.

 

Net interest expense of $467,000 for the nine months ended September 30, 2004 represented an increase of $169,000 from the comparable period in 2003. The increase is attributable to the additional interest expenses relating to the secured promissory notes issued by the Company in November 2003.

 

Other income (expense) for the nine months ended September 30, 2004 was $40,500 as compared to $135,000 for the nine months ended September 30, 2003 mainly due to a gain of $104,000 on the transfer of Oryxe common stock owned by the Company. The gain on the sale of building was $163,900 respectively for the nine months ended September 30, 2004 and September 30, 2003. (See Note 3 to consolidated condensed financial statements).

 

The provision for income taxes was $429,000 for the nine month period ended September 30, 2004 as compared to $790,000 for the nine months ended September 30, 2003. The provisions resulted from an increase in the valuation allowance recorded against a portion of the Company’s deferred tax assets. Such allowance was recorded as management could not determine that it was more likely than not that such deferred tax assets would be realized.

 

Net loss for the nine month period ended September 30, 2004 was approximately $2,123,000 as compared to a net loss of approximately $1,169,000 for the comparable period in the prior year, an increase of $954,000. The increase is a result of the factors discussed above.

 

LIQUIDITY AND CAPITAL RESOURCES

 

At September 30, 2004, the Company had a negative working capital of approximately $519,000 as compared to positive working capital of $704,000 at December 31, 2003, representing a decrease of $1,223,000. Cash used in operating activities during the nine month period ended September 30, 2004 was $1,344,000, primarily consisting of net losses, increases in accounts receivable of $337,000 and inventories of $79,000, offset by decreases in deferred taxes of $429,000 and trademarks and intangible assets of $200,000 and an increase in accounts payable of $377,000. The accounts receivable increase resulted from an increase in the current period net revenues and the inventory increase is a direct result from the Company’s decision to meet potential demands from new international sales. Additionally, the Company provided $30,400 in investing activities and used $306,000 in financing activities which were primarily net reductions in outstanding subordinated secured promissory notes of $644,000 offset by $250,000 in proceeds from notes payable and net proceeds of $77,000 from the credit facility described below.

 

Effective February 26, 2003, the Company entered into a $1,500,000 credit facility (the “Accounts Receivable Purchasing Agreement”) with a financial institution that, unless terminated earlier by its terms, has an initial term

 

16


Table of Contents

through February 26, 2005 with automatic renewals for successive one-year periods thereafter. The Accounts Receivable Purchasing Agreement provides for advances of funds up to 75% of the gross face value of eligible trade accounts receivable based on agreed terms. Such facility is collateralized by accounts receivable, inventory, equipment and other assets. Interest is payable monthly at the financial institution’s base index, which was 4.75% at September 30, 2004, plus 2.25%. Additionally, the Company is obligated under the Accounts Receivable Purchasing Agreement to pay the lender (i) a monthly purchasing fee equal to 0.25% of the total monthly average advances outstanding and (ii) an annual facility fee equal to 0.75% of the purchasing limit which is currently $1,500,000. As of September 30, 2004, $814,290 was outstanding under the credit facility.

 

At September 30, 2004, the Company had accumulated deficit of approximately $12,643,000. Since 2001, the Company has financed its operations primarily through debt financings combined with cash from existing operations. During 2002, the Company raised additional working capital of $1,125,000 through private placements of subordinated secured promissory notes to accredited investors. During 2003, the Company raised additional working capital of $260,000 through a private placement offering of convertible promissory notes and common stock purchase warrants to accredited investors and $2,500,000 through the sale and issue of secured promissory notes and common stock purchase warrants with institutional investors. In August 2004, the Company issued secured promissory notes in the aggregate principal amount of $250,000 to the institutional investors who participated in the November 2003 debt financing. (See Note 7 to consolidated condensed financial statements).

 

In addition to raising capital through debt financings, since 2002 the Company has initiated vigorous expense-reduction strategies, such as reducing personnel, discontinuing certain of its endorsement and sponsorship contracts and aggressively reducing selling and general and administrative expenses. Additionally, the Company improved its credit and collections function and worked with its vendors to improve payment terms. If these measures are not adequate, the Company will pursue additional expense reductions during 2004 or seek to raise additional capital from debt or equity financings. (See Note 7 to consolidated condensed financial statements). The Company is currently exploring additional new financing alternatives. If additional funds are raised by issuing equity securities, dilution to existing stockholders is likely to result. Additionally, pursuant to the securities purchase agreement entered into in November 2003, the holders of the secured promissory notes issued thereunder are required to approve any additional issuances of debt or equity securities by the Company.

 

Pursuant to the securities purchase agreement described above, the Company became subject to certain defined EBITDA ratios and tangible net worth financial covenants, which became effective starting with the period ending March 31, 2004. Specifically, the Company was required to, among other things, maintain a ratio of EBITDA to debt service payments of 0.10x for the twelve months ended September 30, 2004 and to maintain a tangible net worth of $100,000 for the quarter ended June 30, 2004. The Company was not in compliance with the tangible net worth financial covenant for the three months ended June 30, 2004 and did not anticipate that it would be in compliance with the EBITDA ratio covenant by September 30, 2004. On August 11, 2004, the securities purchase agreement was further amended to eliminate the financial covenants for all periods prior to March 31, 2006, at which time the Company will be required to maintain certain levels of tangible net worth and ratios of EBITDA to debt service payments on terms to be agreed to with the holders of the secured promissory note issued under the securities purchase agreement prior to June 30, 2005. The parties to the securities purchase agreement agreed to eliminate the financial covenants until March 31, 2006 partly as a result of management anticipating that the Company would not be in compliance with the applicable financial covenants for the periods prior to March 31, 2006. Once applicable, the financial covenant restrictions could make obtaining additional debt or equity capital more difficult and there is no assurance that the Company could obtain such capital on terms reasonably satisfactory to the Company, or the holders of the secured promissory notes, or at all.

 

Additionally, the securities purchase agreement required the Company to make quarterly royalty payments to the note holders in an aggregate amount (pro rated to each note holder based on the original amount of the notes) equal to (A) the lesser of (i) fifteen percent (15%) of the Incremental Revenue for such quarter and (ii) (a) with respect to the period from November 24, 2003 through December 31, 2004, sixty three one hundredth percent (.63%) of all principal and accrued interest on such notes outstanding as of December 31, 2003, or (b) with respect to any calendar quarter thereafter, one and one half percent (1.5%) of all principal and accrued interest on such notes outstanding as of the midpoint of such calendar quarter. The defined maximum annual expense during the balance of the agreement is $150,000.

 

17


Table of Contents

Management believes that a portion of the shares of common stock in Oryxe Energy International, Inc. owned by the Company could be sold to provide additional working capital. In connection with the amendment to the securities purchase agreement described above, the Company agreed to remit to the holders of secured promissory notes issued thereunder fifty percent of the proceeds in excess of the Company’s cost basis from the sale of the shares of common stock of Oryxe immediately after such sale, thereby reducing the portion of proceeds to be paid to the Company. However, management believes that the aforementioned plans, if successfully executed, will provide adequate financial resources to sustain the Company’s operations and enable the Company to continue as a going concern.

 

RECENT ACCOUNTING ANNOUNCEMENTS

 

STOCK-BASED COMPENSATION

 

The Company accounts for employee stock-based compensation under the “intrinsic value” method prescribed in Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees (“APB 25”), as opposed to the “fair value” method prescribed by Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation (“SFAS 123”). Pursuant to the provisions of APB 25, the Company generally does not record an expense for the value of stock-based awards granted to employees. If proposals currently under consideration by various accounting standard organizations are adopted, such as the Financial Accounting Standards Board Proposed Statement of Financial Accounting Standard, “Share-Based Payment, an amendment of FASB Statements No. 123 and 95”, the Company may be required to treat the value of stock-based awards granted to employees as compensation expense in the future, which could have a material adverse effect on our reported operating results and could negatively affect the price of our Common Stock. If these proposals are adopted, the Company could decide to reduce the number of stock-based awards granted to employees in the future, which could adversely impact its ability to attract qualified candidates or retain existing employees without increasing their cash compensation and, therefore, have a material adverse effect on the Company’s business, results of operations and financial condition.

 

ITEM 3:

 

CONTROLS AND PROCEDURES

 

The Company maintains a system of internal controls and procedures designed to provide reasonable assurance as to the reliability of our published financial statements and other disclosures included in this report. Under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (the “CEO”) and the Chief Financial Officer (the “CFO”), the Company evaluated the effectiveness of the design and operation of its disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the “1934 Act”) as of the end of the period covered by this quarterly report. Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s periodic filings under the 1934 Act.

 

There has been no change in the Company’s internal control over financial reporting during the period covered by this report that has materially affected, or is reasonable likely to materially affect, the Company’s internal control over financial reporting.

 

18


Table of Contents

PROLONG INTERNATIONAL CORPORATION

PART II—OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Reference is made to Note 8 of the notes to consolidated condensed financial statements.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On August 11, 2004 the Company issued four subordinated secured notes payable to accredited investors in the aggregate principal amount of $250,000. The proceeds received by the Company from the sale of subordinated promissory notes were used for general corporate purposes.

 

Item 6. Exhibits

 

10.39    Securities Purchase Agreement dated November 24, 2003 by and among Prolong International Corporation, Prolong Super Lubricants, Inc., Prolong International Holdings Ltd., Prolong International Ltd. and the investors named therein (incorporated by reference to the same number Exhibit to the Registrant’s Form 8-K filed August 20, 2004).
31.1    Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
31.2    Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
32    Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

19


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    PROLONG INTERNATIONAL CORPORATION
Date: November 12, 2004  

/s/ Nicolaas M. Rosier


    Nicolaas M. Rosier
    Chief Financial Officer
    (Principal Financial Officer)

 

20